Answers are grounded in this paper and cite their sources.
A six-step reaction sequence is described for the preparation of compound 1 (NTA3-DTDA), a membrane-penetrating and potent chelator that can be incorporated into liposomes and plasma membrane vesicles containing antigens and thus allowing targeted delivery of such assemblies to a variety of cells for the purposes of eliciting anti-tumour responses. Full spectroscopic characterization of this dendritic-type compound as well as certain of its precursors is reported.
No takes yet. Share an insight, caveat, or question.
Altin et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: